105717
10/13/2023
Timberridge Nursing & Rehabilitation Center
9848 SW 110th St Ocala, FL 34481
F 0580
Level of Harm - Minimal harm or potential for actual harm
Immediately tell the resident, the resident's doctor, and a family member of situations (injury/decline/room, etc.) that affect the resident.
Based on record review and interview, the facility failed to notify the resident representative when there was a change in condition for 1 of 3 residents reviewed for wound care, Resident #2.
Residents Affected - Few
Findings include: Review of Resident #2's physician order dated 1/13/2023 reads, Mupirocin External Ointment 2% (Mupirocin) apply to g-tube [gastrostomy tube] site topically every shift for infected g-tube site applied to g-tube site after cleaning water and soap and pat dry then applied t-sponge. Review of Resident #2's physician order dated 2/27/2023 reads, Triple Antibiotic External Ointment (Neomycin-Bacitracin-Polymyxin) apply to g-tube site topically three times a day for infection of site with foam dressing. Review of Resident #2's physician order dated 2/27/2023 reads, Contact isolation precautions x [times] 10 days for ESBL (Extended Spectrum Beta-Lactamase) e-coli [Escherichia Coli] around G-tube every shift for infection control and resolution for 10 days. Review of Resident #2's physician order dated 2/27/2023 reads, Invanz Injection Solution Reconstituted 1 GM [gram] (Ertapenem Sodium) Inject 1 gram intramuscularly one time a day for g-tube infection for 7 days. Review of Resident #2's physician order dated 2/27/2023 reads, Levaquin Oral Tablet 500 MG [milligrams] (Levofloxacin) Give 1 tablet via G-Tube one time a day for g-tube infection for 7 days. Review of Resident #2's progress note dated 2/27/2023 reads, [Advanced Practice Registered Nurse's Name] aware of wound culture results. Resident on contact isolation. Review of Resident #2's progress note dated 2/21/2023 reads, Optum APRN [Advanced Practice Registered Nurse] [APRN's name] notified of G tube site draining pus, greenish color. She ordered to do wound culture. Stat CBC [Complete Blood Count] and BMP [Basic Metabolic Panel]. Continue Nystatin to armpit for another 5 days. She will come and see her. Review of Resident Infection Report dated 2/28/2023 for Resident #2 reads, Infection site: G-tube site infection, pus present at a wound, skin, or soft tissue site (green pus) . Evaluation . Healthcare acquired: Symptoms were not present at the time of admission and resident meets McGeer's criteria for LTC [Long Term Care] infections . Comments: Resident has chronic g-tube site infections. Culture was positive for e-coli (ESBL) and pseudomonas aeruginosa. Resident has been placed on contact
Page 1 of 4
105717
105717
10/13/2023
Timberridge Nursing & Rehabilitation Center
9848 SW 110th St Ocala, FL 34481
F 0580
precautions.
Level of Harm - Minimal harm or potential for actual harm
Review of Lab Results Report for Wound Culture 1 dated 2/25/2023 for Resident #2 reads, Final Report: Site: G-Tube Site . Result: Escherichia coli (Isolate 1) . Result: Pseudomonas aeruginosa (Isolate 2).
Residents Affected - Few
Review of Resident #2's medical records revealed no evidence indicating that the resident representative was notified of the change in the resident's condition. During an interview on 10/13/2023 at 1:02 PM, the Wound Care Nurse stated, I am new to facility, worked for a month now. Family should always be contacted if there is a change in the wound. I would document if I contacted the family in my evaluation notes, or on the evaluation form. During an interview on 10/13/2023 at 2:30 PM, the Administrator stated, I believe to notify the family for changes in level of care. I think for a new onset in condition potentially for someone who has had a chronic ongoing infection. Isolation is a nursing procedure but not the treatment which would be the same. During an interview on 10/13/2023 at 2:35 PM, the Director of Nursing/Risk Manager stated, I do believe with a resident is placed on isolation, family should be contacted. I mean it is a change in the resident condition. Review of the facility policy and procedure titled Change in a Resident Condition or Status with the last review date of 12/20/2022 reads, Policy: The facility shall promptly notify the resident, his or her Attending Physician, and representative of changes in the resident's medical/mental condition and/or status (e.g., changes in level of care, billing/payments, resident rights, etc.) . Procedure . 3. Unless otherwise instructed by the resident, the Nurse Supervisor/Charge Nurse/Designee will notify the resident's family or representative when . There is a significant change in the residents physical, mental, or psychosocial status.
105717
Page 2 of 4
105717
10/13/2023
Timberridge Nursing & Rehabilitation Center
9848 SW 110th St Ocala, FL 34481
F 0656
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Few
Develop and implement a complete care plan that meets all the resident's needs, with timetables and actions that can be measured. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and interview, the facility failed to develop a comprehensive person-centered care plan for 1 of 3 residents reviewed for diabetes, Resident #1. Finding include: Review of Resident #1's admission record showed the resident was most recently admitted on [DATE] with diagnoses to include type 2 diabetes mellitus with diabetic neuropathy, chronic pulmonary edema, unspecified glaucoma, and acute kidney failure. Review of Resident #1's physician order dated 7/23/2023 reads, Low Concentrated Sweets/NAS (No Added Salt) diet. Regular texture, thin consistency. Review of Resident #1's physician order dated 10/4/2023 reads, Basaglar KwikPen 100 Unit/ML Solution pen-injector. Inject 20 unit subcutaneously at bedtime related to type 2 diabetes mellitus with diabetic neuropathy, unspecified. Review of Resident #1's physician order dated 10/4/2023 reads, Basaglar KwikPen 100 Unit/ML Solution pen-injector. Inject 60 unit subcutaneously one time a day related to type 2 diabetes mellitus with diabetic neuropathy, unspecified. Review of Resident #1's care plan did not reveal a focus area for diabetes. During an interview on 10/13/2023 at 2:05 PM, the Minimum Data Set Coordinator stated, [Resident #1's name] should have been care planned for diabetes since April [2023]. I do not know how it was missed. Review of the facility policy and procedure titled Person Centered Care Planning with the last review date of 12/20/2022 reads, An individualized comprehensive care plan will be person centered and must include measurable objectives and timetables that meet the resident's medical nursing, mental, and psychosocial needs. The care plan will consider the whole person, taking into account each resident's unique qualities, abilities, interests, preferences, and needs.
105717
Page 3 of 4
105717
10/13/2023
Timberridge Nursing & Rehabilitation Center
9848 SW 110th St Ocala, FL 34481
F 0842
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Few
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in accordance with accepted professional standards. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and interview, the facility failed to ensure the medical records were accurate for blood sugar levels for 1 of 3 residents reviewed for diabetes, Resident #1.
Findings include: Review of Resident #1's admission record showed the resident was most recently admitted on [DATE] with diagnoses to include type 2 diabetes mellitus with diabetic neuropathy, chronic pulmonary edema, unspecified glaucoma, and acute kidney failure. Review of Resident #1's physician order dated 10/4/2023 reads, Basaglar KwikPen 100 Unit/ML Solution pen-injector. Inject 20 unit subcutaneously at bedtime related to type 2 diabetes mellitus with diabetic neuropathy, unspecified. Review of Resident #1's physician order dated 10/4/2023 reads, Basaglar KwikPen 100 Unit/ML Solution pen-injector. Inject 60 unit subcutaneously one time a day related to type 2 diabetes mellitus with diabetic neuropathy, unspecified. Review of Resident #1's Medication Administration Record for October 2023 revealed no blood sugar level documented at 9:00 PM on 10/1/2023 through 10/8/2023 for administration of 20 units of Basaglar KwikPen 100 Unit/ML Solution pen-injector at bedtime. Review of Resident #1's Medication Administration Record for October 2023 revealed no blood sugar level documented at 8:00 AM on 10/1/2023 through 10/3/2023 for administration of 60 units of Basaglar KwikPen 100 Unit/ML Solution pen-injector one time a day. Review of Resident #1's Medication Administration Record for September 2023 revealed no blood sugar level documented at 8:00 AM on 9/26/2023 through 9/30/2023 for administration of 60 units of Basaglar KwikPen 100 Unit/ML Solution pen-injector one time a day. Review of Resident #1's Medication Administration Record for September 2023 revealed no blood sugar level documented at 9:00 PM on 9/26/2023 through 9/30/2023 for administration of 20 units of Basaglar KwikPen 100 Unit/ML Solution pen-injector at bedtime. During an interview on 10/13/2023 at 12:35 PM, the Assistant Director of Nursing stated, I do not know what happened in the lapse of time; Why the order did not trigger for the blood sugars to be documented. Normally, it would trigger a section where the nurse records the blood sugars. I would have to see if there were any refusals or if there was a change in medication. Review of the facility policy and procedure titled Documentation, Clinical with the last review date of 12/20/2023 reads, Purpose: The facility clinical staff will document the provision of care and services according to nursing standards and regulatory requirements. When completed, documentation will accurately reflect the clinical care and other services provided to the resident and ensure that the appropriate information is available to all interdisciplinary team members. Documentation in the medical record of each resident should provide: 1. A complete account of the resident's care treatment and response to the care.
105717
Page 4 of 4